Daily Archives: April 2, 2013

Some Digital and Social Media Guidance – FDA Regulation of Pharma Communications in a Digital Era – A White Paper

Posted on April 2, 2013 by Mark Senak

I have been working to assemble  a data base of  FDA/OPDP Warning and NOV letters spanning the years 2004-present, tracking activity through a number of fields.  The database now includes hundreds of letters and covers nearly 1000 violations cited by … Continue reading →

Posted in New and Social Media, Warning Letters | 4 Comments